Position in NVS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,937,402
+$80,366 QoQ
Shares Held
18,743
+0.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#352
of 1,603 holders
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ACADIAN ASSET MANAGEMENT LLC holds $3,615,172,375 across 15 Drug Manufacturers - General names. NVS ranks #13 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BMY |
Bristol Myers Squibb Co
|
11,593,352 | $668,008,942 | |
| 2 | LLY |
ELI LILLY & Co
|
508,522 | $609,936,593 | |
| 3 | ABBV |
AbbVie Inc.
|
1,901,997 | $478,618,525 | |
| 4 | MRK |
Merck & Co., Inc.
|
3,695,329 | $474,849,776 | |
| 5 | AZN |
Astrazeneca PLC
|
2,262,369 | $428,990,409 | |
| 6 | GSK |
GSK plc
|
6,660,434 | $349,139,950 | |
| 7 | JNJ |
Johnson & Johnson
|
1,361,700 | $345,830,949 | |
| 8 | NVO |
Novo Nordisk A S
|
2,736,697 | $131,197,254 |
All Filings in NVS
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,937,402 | 18,743 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $2,857,036 | 18,704 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $2,575,273 | 18,679 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $3,659,071 | 28,533 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $3,424,583 | 28,300 | Shares | Defined | 2025-08-07 | |
| 2025-03-31 | $3,162,464 | 28,368 | Shares | Defined | 2025-05-21 | |
| 2024-12-31 | $3,675,787 | 37,774 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $4,749,750 | 41,295 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $3,193,161 | 29,994 | Shares | Defined | 2024-08-06 | |
| 2024-03-31 | $1,321,235 | 13,659 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $4,862,513 | 48,158 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $1,418,909 | 13,930 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,291,648 | 12,800 | Shares | Defined | 2023-08-07 | |
| 2022-12-31 | $41,549 | 458 | Shares | Defined | 2023-02-14 | |
| 2022-06-30 | $74,724 | 884 | Shares | Defined | 2022-08-09 | |
| 2021-12-31 | $37,437 | 428 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $208,048 | 2,544 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $404,193 | 4,430 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $306,787 | 3,589 | Shares | Defined | 2021-05-11 | |
| 2020-12-31 | $223,987 | 2,372 | Shares | Defined | 2021-02-11 | |
| 2020-03-31 | $62,249 | 755 | Shares | Defined | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||